Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2025MedicinaOpen Access

The Role of Myocardial Revascularization in Ischemic Heart Failure in the Era of Modern Optimal Medical Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

IBIoana-Paula Blaj-TunducCBCiprian BriscCBCristina Mihaela Brisc

Discussion

Loading...

Member takes

Overview

This review examines how revascularization affects outcomes in ischemic heart failure patients, suggesting optimal strategies involving medical therapy and revascularization.

Key Points

  • MYOCARDIAL REVASCULARIZATION plays a key role in treating ischemic heart failure despite advancements in medical therapies.
  • The STICH trial supports CABG as the main revascularization method for multivessel disease, improving long-term prognosis.
  • Older patients with comorbidities require careful evaluation by the Heart Team to determine revascularization options.
  • The REVIVED-BCIS2 trial suggests optimal medical therapy may be preferable over PCI in ischemic cardiomyopathy patients.

Cite This Study

Blaj-Tunduc et al. (2025) studied this question.

synapsesocial.com/papers/689e03e9d61984b91e13d152https://doi.org/10.3390/medicina61081451
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current Concepts in Revascularization for Ischemic Heart Disease With Reduced Ejection Fraction2025
  2. 2Revascularization of coronary artery disease in heart failure. A European Journal of Heart Failure Expert Consensus Statement2026
  3. 3Revascularization in Stable Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials2025
  4. 4Revascularisation strategies for non-acute myocardial ischaemic syndromes.2025 · 1 citations
  5. 5Strategies and Timing of Complete Revascularization in STEMI Patients with Multivessel Coronary Artery Disease2026